Wilrijk, Belgium

Herta Crauwels

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Herta Crauwels: Innovator in HIV Treatment

Introduction

Herta Crauwels is a notable inventor based in Wilrijk, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of HIV infections and AIDS. With a total of two patents to her name, her work has the potential to impact the lives of many individuals affected by these conditions.

Latest Patents

Herta Crauwels' latest patents focus on innovative regimens for treating HIV infections. One of her patents describes a method of treating HIV that involves intramuscular administration of a combination of cabotegravir and rilpivirine. This method allows for administration once every four weeks or less frequently, providing an option to discontinue a first oral anti-retroviral regimen. This approach aims to improve the quality of life for patients by simplifying their treatment regimen.

Career Highlights

Throughout her career, Herta has worked with prominent companies in the pharmaceutical industry. She has been associated with ViiV Healthcare and Janssen Sciences Ireland Unlimited Company. Her experience in these organizations has contributed to her expertise in developing effective treatment options for HIV.

Collaborations

Herta Crauwels has collaborated with esteemed colleagues in her field, including David Margolis and William R. Spreen. These collaborations have likely enriched her research and development efforts, leading to her innovative patents.

Conclusion

Herta Crauwels is a pioneering inventor whose work in HIV treatment showcases her dedication to improving patient care. Her innovative approaches and collaborations highlight her significant contributions to the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…